D E Krantz - JoVE Visualize

Showing results (11-20 of 14) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 14 results.

Journal of Neurobiology|February 14, 2006

Cell-type-specific limitation on in vivo serotonin storage following ectopic expression of the Drosophila serotonin transporter, dSERTSang Ki Park, Rebecca George, Ying Cai, et al.

Molecular Psychiatry|September 29, 2005

Overexpression of the Drosophila vesicular monoamine transporter increases motor activity and courtship but decreases the behavioral response to cocaineH-Y Chang, A Grygoruk, E S Brooks, et al.

The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|September 29, 2000

Synaptic vesicle transporter expression regulates vesicle phenotype and quantal sizeE N Pothos, K E Larsen, D E Krantz, et al.

Molecular Psychiatry|December 12, 2012

Drosophila modifier screens to identify novel neuropsychiatric drugs including aminergic agents for the possible treatment of Parkinson's disease and depressionH O Lawal, A Terrell, H A Lam, et al.

Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 14 results.

Journal of Neurobiology|February 14, 2006

Cell-type-specific limitation on in vivo serotonin storage following ectopic expression of the Drosophila serotonin transporter, dSERTSang Ki Park, Rebecca George, Ying Cai, et al.

Molecular Psychiatry|September 29, 2005

Overexpression of the Drosophila vesicular monoamine transporter increases motor activity and courtship but decreases the behavioral response to cocaineH-Y Chang, A Grygoruk, E S Brooks, et al.

The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|September 29, 2000

Synaptic vesicle transporter expression regulates vesicle phenotype and quantal sizeE N Pothos, K E Larsen, D E Krantz, et al.

Molecular Psychiatry|December 12, 2012

Drosophila modifier screens to identify novel neuropsychiatric drugs including aminergic agents for the possible treatment of Parkinson's disease and depressionH O Lawal, A Terrell, H A Lam, et al.

Pageof 2